Patent · US Active

Method of treatment of SETDB1 expressing cancer

US9683995B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 1, 2015
Grant dateJun 20, 2017
Priority date
Expiry dateMay 1, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/91017
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided herein are methods for diagnosing cancer by determining the level of expression of SETDB1 in a biological sample. Also provided herein are methods for treating cancer by administering an inhibitor of SETDB1 to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.